Robert A. Hodges, J.D., Ph.D.
Robert A. Hodges focuses his practice on domestic and international biotechnology patent prosecution and IP analysis, strategy and counseling. He has extensive scientific and technical expertise in biological therapeutics, receptors, transport, cell signaling, diagnostic and prognostic markers and techniques, genomics, proteomics, transgenic and recombinant organisms, analytic techniques, and recombinant DNA products and procedures. Dr. Hodges has appeared before the United States Patent and Trademark Office in both ex parte and inter partes proceedings, including appeal hearings and interference hearings. He has been lead counsel in and conducted a number of biotech interferences. Prior to becoming an attorney, Dr. Hodges was a Patent Examiner at the United States Patent and Trademark Office and a Patent Agent.
Dr. Hodges was included in The Best Lawyers in America® as one of the best intellectual property lawyers in Atlanta in the specialty of Biotechnology Law (2007–08, 2011). He was also named to the 2005 Super Lawyers list as a “Rising Star."
Dr. Hodges is an inventor in a number of patents including: United States Patent No. 4,472,502 for “Malolactic Gene”, United States Patent No. 5,496,714 for “Modification of Protein by Use of a Controllable Intervening Protein Synthesis”, and United States Patent No. 5,834,247 for “Modified Proteins Comprising Controllable Intervening Protein Sequences or Their Elements Methods of Producing Same and Methods for Purification of a Target Protein Comprised by a Modified Protein"